Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants
Primary Purpose
Neonatal Sepsis, Low Birth Weight
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Chlorhexidine
Normal saline
Sponsored by
About this trial
This is an interventional prevention trial for Neonatal Sepsis focused on measuring chlorhexidine, preterm, newborn, skin condition, temperature, skin flora
Eligibility Criteria
Inclusion Criteria:
- Preterm infants of 28 to 36 weeks' gestation
- Birth weights between 1001 and 2000 g
Exclusion Criteria:
- Infants with one minute Apgar score < 4
- Hemodynamic instability
- Congenital malformations
- Generalized skin disorder and
- Infants who need respiratory support (continuous positive airway pressure and/or intermittent mandatory ventilation) in the first 2-3 hours of life
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Placebo Comparator
No Intervention
Arm Label
Chlorhexidine skin cleansing
Saline skin cleansing
No skin cleansing
Arm Description
Wiping the skin (except the face) once immediately after birth using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)
Wiping the skin (except the face) once immediately after birth using baby wipes containing normal saline
No skin application
Outcomes
Primary Outcome Measures
Median Skin Condition Score on the 9-point Skin Condition Grading Scale Adapted by Darmstadt From Lane et al
The skin condition grading scale assesses the condition of the skin on the abdomen and dorsum of the hands/feet based on drying, erythema, crusting, oozing, etc. on a continuous scale from 1 (normal) to 9 (vesicles or pustules)
Skin Temperature at 30 Min After Intervention
Axillary skin temperature measured by a clinical thermometer kept in axilla for 3 minutes
Number of Participants With Positive Skin Culture at Axilla
Occurrence of any bacterial flora irrespective of the colony count in the skin swabs from axilla at 24 hrs after intervention
Secondary Outcome Measures
Incidence of Clinical and Culture Positive Sepsis
Infants with symptoms and/or signs suggestive of sepsis and a positive blood culture (with known pathogens and coagulase negative staphylococcus) were diagnosed to have culture positive sepsis; Those with negative cultures but with positive sepsis screen were classified as having clinical sepsis
Full Information
NCT ID
NCT00947518
First Posted
April 20, 2009
Last Updated
March 19, 2018
Sponsor
All India Institute of Medical Sciences, New Delhi
1. Study Identification
Unique Protocol Identification Number
NCT00947518
Brief Title
Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants
Official Title
Does Skin Cleansing With Chlorhexidine Affect Skin Condition, Temperature and Colonization in Hospitalized Preterm Low Birth Weight Infants?: A Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2009
Overall Recruitment Status
Completed
Study Start Date
August 2005 (undefined)
Primary Completion Date
February 2006 (Actual)
Study Completion Date
February 2006 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
All India Institute of Medical Sciences, New Delhi
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to examine if single skin cleansing with 0.25% chlorhexidine affects skin condition, temperature, and bacterial colonization in stable preterm (28-36 weeks gestational age) low birth weight (1001-2000 g) infants admitted in a health facility.
Detailed Description
Infections are the leading cause of death in neonates admitted to hospital - studies from developing countries suggest that about 25-71% of deaths occurring in neonatal intensive care units are secondary to infections.Such high infection-related mortality mandates an urgent implementation of simple and effective measures to prevent the occurrence of infections in these units.
The majority of neonatal infections occur in the first two weeks of life, when the epidermal barrier is immature and functionally compromised. Topical application of antiseptics until the skin matures could theoretically prevent skin colonization and reduce the incidence of systemic infections in neonates. Chlorhexidine, a broad-spectrum antiseptic used frequently for umbilical cord care in neonates, is now being evaluated for topical application to the skin. Hospital-based studies, involving predominantly term infants, have shown reductions in skin flora8 and a reduction in the incidence of sepsis following topical chlorhexidine application. In a community-based study in Nepal, a single skin cleansing with 0.25% chlorhexidine resulted in reduction in mortality among low birth weight infants; though the mechanism of the impact could not be determined, it was presumably due to increased susceptibility to transcutaneous sepsis in the low birth weight group.
Since the risk of infection in neonates is inversely related to their gestation, it is essential to evaluate the effect and the mechanism of such intervention in preterm neonates. These infants are, however, more prone to develop skin reactions following use of topical antiseptics. Preterm infants are also more prone to develop hypothermia following bathing/cleansing with antiseptic solution(s).
Since few studies have evaluated the effects of topical application of chlorhexidine in preterm infants admitted in a health care facility, we conducted the present study to examine if single skin cleansing with 0.25% chlorhexidine immediately after birth affects skin condition, temperature, and colonization in hospitalized preterm low birth weight infants.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neonatal Sepsis, Low Birth Weight
Keywords
chlorhexidine, preterm, newborn, skin condition, temperature, skin flora
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Chlorhexidine skin cleansing
Arm Type
Experimental
Arm Description
Wiping the skin (except the face) once immediately after birth using baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)
Arm Title
Saline skin cleansing
Arm Type
Placebo Comparator
Arm Description
Wiping the skin (except the face) once immediately after birth using baby wipes containing normal saline
Arm Title
No skin cleansing
Arm Type
No Intervention
Arm Description
No skin application
Intervention Type
Drug
Intervention Name(s)
Chlorhexidine
Intervention Description
Baby wipes containing 0.25% free chlorhexidine (equivalent to 0.44% chlorhexidine digluconate)
Intervention Type
Drug
Intervention Name(s)
Normal saline
Intervention Description
Cleansing the skin (except the face)with baby wipes containing normal saline
Primary Outcome Measure Information:
Title
Median Skin Condition Score on the 9-point Skin Condition Grading Scale Adapted by Darmstadt From Lane et al
Description
The skin condition grading scale assesses the condition of the skin on the abdomen and dorsum of the hands/feet based on drying, erythema, crusting, oozing, etc. on a continuous scale from 1 (normal) to 9 (vesicles or pustules)
Time Frame
At 24 hours
Title
Skin Temperature at 30 Min After Intervention
Description
Axillary skin temperature measured by a clinical thermometer kept in axilla for 3 minutes
Time Frame
at 30 min after intervention
Title
Number of Participants With Positive Skin Culture at Axilla
Description
Occurrence of any bacterial flora irrespective of the colony count in the skin swabs from axilla at 24 hrs after intervention
Time Frame
24 hours after intervention
Secondary Outcome Measure Information:
Title
Incidence of Clinical and Culture Positive Sepsis
Description
Infants with symptoms and/or signs suggestive of sepsis and a positive blood culture (with known pathogens and coagulase negative staphylococcus) were diagnosed to have culture positive sepsis; Those with negative cultures but with positive sepsis screen were classified as having clinical sepsis
Time Frame
First week of life
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Hour
Maximum Age & Unit of Time
3 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Preterm infants of 28 to 36 weeks' gestation
Birth weights between 1001 and 2000 g
Exclusion Criteria:
Infants with one minute Apgar score < 4
Hemodynamic instability
Congenital malformations
Generalized skin disorder and
Infants who need respiratory support (continuous positive airway pressure and/or intermittent mandatory ventilation) in the first 2-3 hours of life
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mari J Sankar, MD DM
Organizational Affiliation
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Vinod K Paul, MD PhD
Organizational Affiliation
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ashok K Deorari, MD MNAMS
Organizational Affiliation
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Gary L Darmstadt, MD MS
Organizational Affiliation
Department of International Health, Bloomberg School of Public Health, Johns Hopkins University
Official's Role
Study Chair
12. IPD Sharing Statement
Learn more about this trial
Safety of Skin Cleansing With Chlorhexidine in Preterm Low Birth Weight Infants
We'll reach out to this number within 24 hrs